Sino Biopharmaceutical Li... (SBHMY)

PNK: SBHMY · Real-Time Price · USD

9.48

-0.82 (-7.96%)

At close: Apr 21, 2025, 3:37 PM

Sino Biopharmaceutical Cash Flow Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Mar 31, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	1.51B	1.51B	n/a	629.39M	629.39M	311.27M	311.27M	960.52M	960.52M	3.06B	3.06B	6.57B	1.91B	920.59M	637.42M	364.82M	875.79M	506.02M	811.17M	587.65M	856.7M	6.85B	835.59M	594.57M	771.1M	365.99M	704.38M	521.57M	579.01M	241.89M	472.43M	448.04M	427.56M
Depreciation & Amortization	255.12M	255.12M	n/a	326.6M	326.6M	279.43M	279.43M	204.34M	204.34M	254.79M	254.79M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a	14.86M	14.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	n/a	n/a	n/a	n/a	n/a	510M	n/a	n/a	n/a	609.07M	609.07M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	42.7M	42.7M	42.7M	n/a	86.36M	86.36M	86.36M	n/a	113.59M	113.59M	113.59M	n/a	79.38M	79.38M
Other Non-Cash Items	-224.45M	-224.45M	n/a	379.56M	379.56M	463.79M	567.41M	794.75M	794.75M	-1.73B	-1.73B	-6.57B	-1.91B	-920.59M	-637.42M	-364.82M	-875.79M	-506.02M	-811.17M	743.51M	474.46M	-5.51B	-835.59M	679.02M	502.49M	907.6M	-704.38M	-521.57M	-579.01M	-241.89M	-472.43M	-448.04M	-427.56M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	n/a	n/a	103.62M	n/a	n/a	n/a	-73.77M	-73.77M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Cash Flow	1.54B	1.54B	n/a	1.34B	1.34B	1.16B	1.16B	1.97B	1.97B	1.52B	1.52B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.33B	1.33B	1.33B	n/a	1.27B	1.27B	1.27B	n/a	933.13M	933.13M	933.13M	n/a	772.71M	772.71M
Capital Expenditures	-203.75M	-203.75M	n/a	-376.95M	-376.95M	-308.18M	-308.18M	-313.49M	-313.49M	-564.26M	-564.26M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-433.49M	-433.49M	-433.49M	n/a	-423.18M	-423.18M	-423.18M	n/a	-365.05M	-365.05M	-365.05M	n/a	-233.81M	-233.81M
Cash Acquisitions	n/a	n/a	n/a	229K	229K	n/a	n/a	n/a	n/a	-20.8M	-20.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-723.7M	-723.7M	-723.7M	n/a	-613.05M	-613.05M	-613.05M	n/a	-352.24M	-352.24M	-352.24M	n/a	-341.97M	-341.97M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	228.57M	228.57M	228.57M	n/a	541.82M	541.82M	541.82M	n/a	104.77M	104.77M	104.77M	n/a	35.51M	35.51M
Other Investing Acitivies	-816.71M	-816.71M	n/a	-1.66B	-1.66B	1.27B	1.27B	-2.68B	-2.68B	1.36B	1.36B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	928.62M	928.62M	928.62M	n/a	494.42M	494.42M	494.42M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.02B	-1.02B	n/a	-2.04B	-2.04B	959.42M	959.42M	-2.99B	-2.99B	770M	770M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-180.78M	-180.78M	n/a	-117.85M	-117.85M	-29.15M	-29.15M	-404.66M	-404.66M	-166.47M	-166.47M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-8.01M	-8.01M	-8.01M	n/a	-151.1M	-151.1M	-151.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	-633.81M	n/a	n/a	n/a	-469.24M	-469.24M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-204.92M	-204.92M	-204.92M	n/a	-177.58M	-177.58M	-177.58M	n/a	-112.49M	-112.49M	-112.49M	n/a	-99.55M	-99.55M
Other Financial Acitivies	-1.87B	-1.87B	n/a	-1.9B	-1.9B	-199.97M	-833.78M	-325.61M	-325.61M	-596.08M	-596.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-799.93M	-799.93M	-799.93M	n/a	-167.67M	-167.67M	-167.67M	n/a	-178.35M	-178.35M	-178.35M	n/a	n/a	n/a
Financial Cash Flow	-2.05B	-2.05B	n/a	-2.02B	-2.02B	-862.93M	-862.93M	-730.26M	-730.26M	-1.23B	-1.23B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1B	-1B	-1B	n/a	-345.25M	-345.25M	-345.25M	n/a	-290.85M	-290.85M	-290.85M	n/a	n/a	n/a
Net Cash Flow	-1.52B	-1.52B	n/a	-2.68B	-2.68B	1.29B	1.29B	-1.77B	-1.77B	785.61M	785.61M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.1B	1.1B	1.1B	n/a	n/a	n/a	n/a	n/a	47.4M	47.4M	47.4M	n/a	n/a	n/a
Free Cash Flow	1.34B	1.34B	n/a	958.61M	958.61M	849.93M	849.93M	1.66B	1.66B	951.11M	951.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	897.67M	897.67M	897.67M	n/a	850.41M	850.41M	850.41M	n/a	568.08M	568.08M	568.08M	n/a	538.9M	538.9M